|70Ventures||Lithuania, Vilniaus Apskritis, Vilnius|
|Alive Ideas||France, Ile-de-France, Paris|
|Aviva Ventures||England, London, United Kingdom|
|Burda International||Bayern, Germany, Munich|
|Caitong Capital||China, Hangzhou, Zhejiang|
|Calyon Financial||Chicago, Illinois, United States|
|Garnett & Helfrich Capital||California, San Mateo, United States|
|Huaneng Capital||Beijing, Beijing, China|
|IntelleGrow||India, Maharashtra, Mumbai|
|Oxford University Innovation||Oxford, Oxfordshire, United Kingdom|
|Partners HealthCare Innovation||Cambridge, Massachusetts, United States|
|ROCA Partners||Beverly Hills, California, United States|
|San Diego Venture Partners||-|
|Shanghai Bingye Qiye Guanlizhongxin||China, Shanghai|
|Shinkin Capital||Japan, Tokyo|
|TDM Growth Partners||Australia, New South Wales, Sydney|
|University Medical Center Groningen||Groningen, Groningen, The Netherlands|
|Weston Presidio Capital||Boston, Massachusetts, United States|
|$7M||08 Feb 2022||Sao Paulo, São Paulo, Brazil|
|$21M||16 Jun 2020||São Paulo, São Paulo, Brazil|
|$21M||01 Jun 2020||São Paulo, São Paulo, Brazil|
|$4M||01 Jun 2018||Brazil, São Paulo|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.